Montelukast Prescribing at VIDA HEALTHCARE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
4,847
Total Quantity
117.2K
NHS Cost
£5.8K
vs National Avg
+607.9%
VIDA HEALTHCARE prescribed 4,847 items of Montelukast over the last 12 months at a cost of £5,803 to the NHS. This is 607.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
414
Jul 2026
398
Jul 2026
431
Jul 2026
390
Jul 2026
373
Jul 2026
418
Jul 2026
406
Jul 2026
408
Jul 2026
430
Jul 2026
384
Jul 2026
412
Jul 2026
383
Prescribing Details
| Total Items | 4,847 |
|---|---|
| Total Quantity | 117,246 |
| Total NHS Cost | £5,803 |
| Presentations | 4 different forms |
| vs National Average | +607.9% |
Montelukast Prescribing Comparison
| This practice | 4,847 items |
|---|---|
| National average per practice | 685 items |
| Difference | +607.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.